“China Economic and Social Affairs Signal | Commercial Shift Acceleration of Domestic Medical Robots” published by China Economic Information Service reports that at a large-scale exhibition site held in Beijing, the robotic arm of a domestic orthopedic surgical robot moved slowly to accurately complete positioning and simulated surgical operations on a skeletal model. On the next screen, the 3D operation plan was displayed in real time. At the exhibition, domestic medical robots attracted much attention; outside of the exhibition, their commercialization process accelerated. According to data from the General Administration of Customs, in the first half of this year, China's surgical robot exports were 480 million yuan, an increase of 3.3 times over the previous year, and the export market increased from 23 to 49 in the same period in 2025; in the public hospital endoscopic robot bidding market, domestic brands accounted for 63% of the bid volume in the first half of this year, surpassing imported brands; agencies expect the compound growth rate of China's surgical robot market to reach 33.3% in the next 5 years, which is significantly higher than the global level. These three sets of data simultaneously outline an upward market curve. Domestic medical robots have not ushered in a single breakthrough in any technology, but have entered a critical period of accelerated commercialization, from overseas deployment to overtaking in segmented fields, and from scale expansion to multi-dimensional acceleration in profit realization by leading companies.

“China Economic and Social Affairs Signal | Commercial Shift Acceleration of Domestic Medical Robots” published by China Economic Information Service reports that at a large-scale exhibition site held in Beijing, the robotic arm of a domestic orthopedic surgical robot moved slowly to accurately complete positioning and simulated surgical operations on a skeletal model. On the next screen, the 3D operation plan was displayed in real time. At the exhibition, domestic medical robots attracted much attention; outside of the exhibition, their commercialization process accelerated. According to data from the General Administration of Customs, in the first half of this year, China's surgical robot exports were 480 million yuan, an increase of 3.3 times over the previous year, and the export market increased from 23 to 49 in the same period in 2025; in the public hospital endoscopic robot bidding market, domestic brands accounted for 63% of the bid volume in the first half of this year, surpassing imported brands; agencies expect the compound growth rate of China's surgical robot market to reach 33.3% in the next 5 years, which is significantly higher than the global level. These three sets of data simultaneously outline an upward market curve. Domestic medical robots have not ushered in a single breakthrough in any technology, but have entered a critical period of accelerated commercialization, from overseas deployment to overtaking in segmented fields, and from scale expansion to multi-dimensional acceleration in profit realization by leading companies.